151 related articles for article (PubMed ID: 18621635)
21. Current status of capecitabine in the treatment of colorectal cancer.
Rothenberg ML
Oncology (Williston Park); 2002 Dec; 16(12 Suppl No 14):16-22. PubMed ID: 12520635
[TBL] [Abstract][Full Text] [Related]
22. Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients.
Schmoll HJ; Cartwright T; Tabernero J; Nowacki MP; Figer A; Maroun J; Price T; Lim R; Van Cutsem E; Park YS; McKendrick J; Topham C; Soler-Gonzalez G; de Braud F; Hill M; Sirzén F; Haller DG
J Clin Oncol; 2007 Jan; 25(1):102-9. PubMed ID: 17194911
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant therapy of colon cancer: current status and future directions.
Chung KY; Saltz LB
Cancer J; 2007; 13(3):192-7. PubMed ID: 17620769
[TBL] [Abstract][Full Text] [Related]
24. [Present status of chemotherapy for colorectal cancer in countries outside of Japan].
Doi T; Ohtsu A
Nihon Rinsho; 2003 Sep; 61 Suppl 7():368-73. PubMed ID: 14574915
[No Abstract] [Full Text] [Related]
25. Cetuximab plus XELIRI or XELOX for first-line therapy of metastatic colorectal cancer.
Moosmann N; Heinemann V
Clin Colorectal Cancer; 2008 Mar; 7(2):110-7. PubMed ID: 18501070
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant chemotherapy of colon cancer: lymph node involvement without metastases.
Prescrire Int; 2006 Jun; 15(83):109-1. PubMed ID: 16764102
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant chemotherapy for localised colon cancer. Fluorouracil + folinic acid for node-positive, non-metastatic disease.
Prescrire Int; 2011 Feb; 20(113):46-9. PubMed ID: 21488594
[TBL] [Abstract][Full Text] [Related]
28. Pharmacoeconomic analysis of capecitabine versus 5-fluorouracil/leucovorin as adjuvant therapy for stage III colon cancer in Taiwan.
Hsu TC; Chen HH; Yang MC; Wang HM; Chuang JH; Jao SW; Chiang HC; Wen CY; Tseng JH; Chen LT
Value Health; 2011; 14(5):647-51. PubMed ID: 21839401
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant therapy of colon cancer: a review.
Hobday TJ; Erlichman C
Clin Colorectal Cancer; 2002 Feb; 1(4):230-6. PubMed ID: 12450421
[TBL] [Abstract][Full Text] [Related]
30. Colorectal cancer: chemotherapy treatment overview.
Royce ME; Medgyesy D; Zukowski TH; Dwivedy S; Hoff PM; Pazdur R
Oncology (Williston Park); 2000 Dec; 14(12 Suppl 14):40-6. PubMed ID: 11200148
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.
André T; de Gramont A; Vernerey D; Chibaudel B; Bonnetain F; Tijeras-Raballand A; Scriva A; Hickish T; Tabernero J; Van Laethem JL; Banzi M; Maartense E; Shmueli E; Carlsson GU; Scheithauer W; Papamichael D; Möehler M; Landolfi S; Demetter P; Colote S; Tournigand C; Louvet C; Duval A; Fléjou JF; de Gramont A
J Clin Oncol; 2015 Dec; 33(35):4176-87. PubMed ID: 26527776
[TBL] [Abstract][Full Text] [Related]
32. [Recent results of irinotecan therapy in colorectal cancer].
Láng I; Hitre E
Magy Onkol; 2004; 48(4):281-8. PubMed ID: 15655572
[TBL] [Abstract][Full Text] [Related]
33. [IDEA study (International Duration Evaluation of Adjuvant Chemotherapy) for patients with stage III colon cancer: Possibility of reducing to 3 months treatment for 60% of the patients!].
André T; Taieb J;
Bull Cancer; 2018 Jun; 105(6):546-547. PubMed ID: 29776587
[No Abstract] [Full Text] [Related]
34. Neoadjuvant chemoradiation for rectal cancer: is more better?
Patel A; Puthillath A; Yang G; Fakih MG
Oncology (Williston Park); 2008 Jun; 22(7):814-26; discussion 826, 828-31, 836. PubMed ID: 18619122
[TBL] [Abstract][Full Text] [Related]
35. [Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial].
Kubicka S
Strahlenther Onkol; 2016 Jul; 192(7):505-6. PubMed ID: 27272658
[No Abstract] [Full Text] [Related]
36. Developments in combination chemotherapy for colorectal cancer.
Goetz MP; Grothey A
Expert Rev Anticancer Ther; 2004 Aug; 4(4):627-37. PubMed ID: 15270666
[TBL] [Abstract][Full Text] [Related]
37. Palliative treatment for elderly patients with colon cancer in ten Italian medical oncology units.
Pasetto LM; Falci C; Rizzo E; De Salvo GL; Gasparini G; D'Andrea M; Bajetta E; Platania M; Alabiso O; Miraglia S; Oniga F; Biason R; Chetrì MC; Fedele P; Massara G; Romaniello I; Giordano M; Luchena G; Buzzi F; Ricotta R; Siena S; Monfardini S
Anticancer Res; 2008; 28(3B):1813-20. PubMed ID: 18630465
[TBL] [Abstract][Full Text] [Related]
38. Short time infusion of bevacizumab in combination with 5FU-based chemotherapy as first-line therapy in a non-selective patient group with metastatic colorectal cancer.
Dohn LH; Jensen BV; Larsen FO
Acta Oncol; 2010 Apr; 49(3):395-6. PubMed ID: 20001495
[No Abstract] [Full Text] [Related]
39. Update: NCCN colon and rectal cancer clinical practice guidelines.
Kiel K; Engstrom PF
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-14-8. PubMed ID: 23570093
[No Abstract] [Full Text] [Related]
40. Oral capecitabine: bridging the Atlantic divide in colon cancer treatment.
Van Cutsem E; Verslype C; Tejpar S
Semin Oncol; 2005 Feb; 32(1):43-51. PubMed ID: 15726505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]